Experienced in Myeloproliferative Neoplasms (MPN)

Najib Dally

Safed, Z, IL 
Experienced in Myeloproliferative Neoplasms (MPN)
Safed, Z, IL 
OverviewLocationsClinical Research

Overview

Najib Dally practices in Safed, Israel. Mr. Dally is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Acquired Hemophilia.

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Myeloproliferative Neoplasms (MPN).

Gender
Male

Locations

Safed, Z, Israel
Other Locations
Nahariyya, Z 52900, Israel
Haifa, HA, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomised, Single-blind, Placebo-controlled, Phase 1, Single-ascending and Multiple-dose Study in Adult Subjects With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome to Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124.
A Randomised, Single-blind, Placebo-controlled, Phase 1, Single-ascending and Multiple-dose Study in Adult Subjects With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome to Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124.
Enrollment Status: Completed
Publish Date: January 03, 2024
Intervention Type: Drug
Study Drug: SLN124
Study Phase: Phase 1

33 Total Publications

AFTER YEARS OF WANDERING, CHRONIC MYELOMONOCYTIC LEUKEMIA FINALLY FOUND ITS PLACE: A HISTORICAL PERSPECTIVE
AFTER YEARS OF WANDERING, CHRONIC MYELOMONOCYTIC LEUKEMIA FINALLY FOUND ITS PLACE: A HISTORICAL PERSPECTIVE
Journal: Harefuah
Published: May 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dally's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile